We are live on
!
Find out more
TCM
Trybe Capital Management Portfolio holdings
AUM
$1.09B
1-Year Est. Return
249.75%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+249.75%
3 Year Est. Return
+680.91%
5 Year Est. Return
+833.26%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$11.7M
(+7.1%)
Cap. Flow
+$9.31M
Cap. Flow
% of AUM
5.3%
Top 10 Holdings %
Top 10 Hldgs %
91.28%
Holding
14
New
2
Increased
–
Reduced
–
Closed
2
Avg Time Held
2.4
quarters
Top 10 Avg Time Held
2.4
quarters
Top 20 Avg Time Held
2.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$14.7M |
| 2 |
Marvell Technology
MRVL
|
+$6.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRNG
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
|
+$5.99M |
| 2 |
ARK Genomic Revolution ETF
ARKG
|
+$5.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 58.4% |
| 2 | Communication Services | 16.22% |
| 3 | Consumer Discretionary | 8.95% |
| 4 | Financials | 8.45% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$5.72T
| $24.6M | 13.99% |
1,185,600
| – | – |
2020 Q4
3 quarters
|
|
2
Alphabet (Google) Class A
GOOGL
$4.22T
| $19.8M | 11.26% |
147,920
| – | – |
2020 Q4
3 quarters
|
|
3
Microsoft
MSFT
$3.91T
| $17.7M | 10.11% |
62,952
| – | – |
2020 Q4
3 quarters
|
|
4
ServiceNow
NOW
$141B
| $17.1M | 9.75% |
137,610
| – | – |
2020 Q4
3 quarters
|
|
5
Amazon
AMZN
$2.72T
| $15.7M | 8.95% |
95,740
| – | – |
2020 Q4
3 quarters
|
|
6
PayPal
PYPL
$46B
| $14.8M | 8.45% |
57,032
| – | – |
2020 Q4
3 quarters
|
|
|
7
Ginkgo Bioworks
DNA
$976M
| $14M | 7.97% |
+30,200
| New | +$14.7M |
2021 Q3
0 quarters
|
|
8
Salesforce
CRM
$189B
| $12.6M | 7.16% |
46,384
| – | – |
2020 Q4
3 quarters
|
|
9
Apple
AAPL
$4.87T
| $12.6M | 7.16% |
88,837
| – | – |
2020 Q4
3 quarters
|
|
10
Palantir
PLTR
$453B
| $11.4M | 6.47% |
472,953
| – | – |
2021 Q1
2 quarters
|
|
11
Match Group
MTCH
$9.28B
| $8.72M | 4.96% |
55,523
| – | – |
2020 Q4
3 quarters
|
|
|
12
Marvell Technology
MRVL
$245B
| $6.6M | 3.76% |
+109,407
| New | +$6.56M |
2021 Q3
0 quarters
|
|
|
13
ARK Genomic Revolution ETF
ARKG
$2.26B
| – | – |
-64,381
| Closed | -$5.96M | – |
|
|
SRNG
14
DELISTED
Soaring Eagle Acquisition Corp. Class A Ordinary Share
SRNG
| – | – |
-601,698
| Closed | -$5.99M | – |
|
Similar funds
AA
LEA
RA
AAIM
CFFNO
IF
APC
SAM
Trybe Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Trybe Capital Management held 14 positions worth $176M, up 7.1% from $164M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Trybe Capital Management deployed $9.31M of net new capital in Q3 2021, opening 2 new positions. Its largest new stake was Ginkgo Bioworks: 30,200 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 56% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the most notable exit was Soaring Eagle Acquisition Corp. Class A Ordinary Share, an estimated $5.99M sold.
- Trybe Capital Management's largest Q3 2021 buy was Ginkgo Bioworks: 30,200 shares worth $14M.
- Trybe Capital Management fully exited Soaring Eagle Acquisition Corp. Class A Ordinary Share in Q3 2021, selling an estimated $5.99M.
- Trybe Capital Management's ten largest holdings make up 91% of its $176M portfolio in Q3 2021.
- Trybe Capital Management opened 2 new positions and closed 2 in Q3 2021.
- Trybe Capital Management's portfolio value rose 7.1% quarter-over-quarter to $176M.
Based on Trybe Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.